SCNX (Scienture Holdings) GF Value : $4.28 (As of Mar. 04, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Scienture Holdings GF Value?

As of today (2025-03-04), Scienture Holdings's share price is $2.08. Scienture Holdings's GF Value is $4.28. Therefore, Scienture Holdings's Price-to-GF-Value for today is 0.49. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Scienture Holdings is Possible Value Trap, Think Twice.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Please note that "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

Scienture Holdings (NAS:SCNX) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) A sufficient margin of safety exists only when the stock is undervalued.

Scienture Holdings's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	2.08	/	4.28
	=	0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scienture Holdings GF Value Related Terms

Thank you for viewing the detailed overview of Scienture Holdings's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Scienture Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Scienture Holdings Inc (NAS:SCNX) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

4E4:Germany

Address

2420 Brunello Trace, Lutz, FL, USA, 33558

Website

vhttps://www.scienture.com

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Executives

A. Jeffrey Newell	director	645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell	director	17537 DARBY LANE, LUTZ FL 33558
Janet Huffman	officer: CFO, PAO, PFO	5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson	director	17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings	director	3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel	director, 10 percent owner, officer: President	17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts	director	PO BOX 15012, SARASOTA FL 34277
Gary Augusta	director	700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss	officer: CFO	17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu	director, 10 percent owner, officer: CEO	8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida	director	1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope	director	4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu	10 percent owner	17537 DARBY LANE, LUTZ FL 33558